» Articles » PMID: 30648774

Bleed Volume of Experimental Knee Haemarthrosis Correlates with the Subsequent Degree of Haemophilic Arthropathy

Overview
Journal Haemophilia
Specialty Hematology
Date 2019 Jan 17
PMID 30648774
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Haemophilic arthropathy is the main morbidity of haemophilia. The individual pathological response to the same number of clinically evident joint bleeds is highly variable; thus, it remains unknown if certain joint bleeding characteristics are critical for the development of arthropathy.

Aim: To study the relation between bleed volume and subsequent development of arthropathy, we aimed to develop quantitative in vivo imaging of active joint bleeds in a mouse model of haemophilia.

Methods: Haemophilia A (F8-KO) and wild-type (WT) mice were IV-dosed with a micro-CT blood pool contrast agent prior to an induced knee haemarthrosis or sham procedure. The mice were micro-CT scanned five times the following 2 days to characterise and quantify the induced haemarthrosis in vivo. On Day 14, the mice were euthanized and pathological changes evaluated by histology and micro-CT. Additionally, bleeding characteristics in vehicle-treated F8-KO mice were compared with those of recombinant FVIII (rFVIII)-treated F8-KO mice.

Results: F8-KO mice had a significantly larger bleed volume than WT mice at all scan time points. The bleed volume 12 hours after induction of haemarthrosis correlated with the subsequent degree of arthropathy. Presence of µCT-detectable bone pathology was associated with a significantly increased bleed volume among F8-KO mice. rFVIII treatment significantly reduced bleed volume in F8-KO mice.

Conclusion: Quantitative in vivo contrast-enhanced micro-CT imaging can be used to characterize and quantify joint bleeds in a mouse model of haemophilic arthropathy. The bleed volume correlates with the subsequent degree of arthropathy.

Citing Articles

AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia.

Sarangi P, Senthilkumar M, Amit S, Kumar N, Jayandharan G J Cell Mol Med. 2024; 28(11):e18460.

PMID: 38864710 PMC: 11167708. DOI: 10.1111/jcmm.18460.


On-demand treatment with the iron chelator deferasirox is ineffective in preventing blood-induced joint damage in haemophilic mice.

Pulles A, van Vulpen L, Coeleveld K, Mastbergen S, Schutgens R, Lafeber F Haemophilia. 2021; 27(4):648-656.

PMID: 34043875 PMC: 8361985. DOI: 10.1111/hae.14328.


Initial joint bleed volume in a delayed on-demand treatment setup correlates with subsequent synovial changes in hemophilic mice.

Vols K, Kjelgaard-Hansen M, Dan Ley C, Hansen A, Petersen M Animal Model Exp Med. 2020; 3(2):160-168.

PMID: 32613175 PMC: 7323705. DOI: 10.1002/ame2.12118.


In vivo fluorescence molecular tomography of induced haemarthrosis in haemophilic mice: link between bleeding characteristics and development of bone pathology.

Vols K, Kjelgaard-Hansen M, Ley C, Hansen A, Petersen M BMC Musculoskelet Disord. 2020; 21(1):241.

PMID: 32290832 PMC: 7158129. DOI: 10.1186/s12891-020-03267-5.


Proteoglycan synthesis rate as a novel method to measure blood-induced cartilage degeneration in non-haemophilic and haemophilic rats.

Pulles A, Vols K, Christensen K, Coeleveld K, Hansen A, van Vulpen L Haemophilia. 2020; 26(3):e88-e96.

PMID: 32212362 PMC: 7318356. DOI: 10.1111/hae.13969.